Skip to main content
Log in

Efficacia della terapia di mantenimento con octreotide orale sul controllo biochimico dell’acromegalia

  • NOVITÀ IN ENDOCRINOLOGIA
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Melmed S, Popovic V, Bidlingmaier M et al. (2015) Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J Clin Endocrinol Metab 100(4):1699–1708

    Article  CAS  Google Scholar 

  2. Fleseriu M, Dreval AV, Pokramovich Y et al. (2021) A phase 3 large international noninferiority trial (MPOWERED): assessing maintenance of response to oral octreotide capsules in comparison to injectable somatostatin receptor ligands. J Endocr Soc 5(Suppl):A517. 1

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emanuela Arvat.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bombonato, M., Arvat, E. Efficacia della terapia di mantenimento con octreotide orale sul controllo biochimico dell’acromegalia. L'Endocrinologo 22, 581–582 (2021). https://doi.org/10.1007/s40619-021-00996-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-021-00996-0

Navigation